Live varicella vaccine (Shanghai Rongsheng Biotech)

水痘减毒活疫苗（上海荣盛生物药业有限公司）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLive varicella vaccine (Shanghai Rongsheng Biotech)
Drug Alias Name韦可邦VacVar
ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHerpes ZosterChickenpoxVaricella Zoster Virus Infection +[4] 
Global Approved IndicationsVaricella Zoster Virus Infection
Approved Indications in ChinaVaricella Zoster Virus Infection
Original Approved Country/TerritoryMainland China
Original Approved Date2016/10/25
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Rongsheng Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Rongsheng Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsHerpes ZosterChickenpoxVaricella Zoster Virus Infection +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeJ07BK01
Related LinksN/A